Gemcitabine

Gemcitabine,

Gemcitabine Hydrochloride

6.4 Moderate risk

Gemcitabine & Thrombocytopenia

7.0%

of users reported Thrombocytopenia

62.6%

also reported Severe reaction

50.1%

are women

Most common medical consequences

Severe reaction
62.6%
Hospitalization
24.2%
Death
9.5%
Life-threatening condition
3.5%
Disability
0.1%

Have you experienced any negative side effects from this medication?

Gemcitabine: general information

Most common side effects (247)

Most commonly affected ages

0 - 9 years
0.1%
10 - 19 years
2.3%
20 - 29 years
2.1%
30 - 39 years
4.5%
40 - 49 years
9.5%
50 - 59 years
20.7%
60 - 69 years
32.3%
70 - 79 years
25.0%
80 - 89 years
3.3%
90 - 99 years
0.2%